Kane Biotech Inc. (TSXV:KNE) announced that it has engaged Research Capital Corporation as Kane?s exclusive financial advisor (the ?Advisor?) to conduct a strategic review process for its STEM Animal Health Inc. business division (?STEM?). Kane is considering a variety of strategic alternatives to maximize shareholder value with regards to STEM. These alternatives could include, among other things, the sale of all or part of its assets in STEM, a merger or other business combinations with another party, or any other strategic transaction.

There can be no assurance that the process will result in any transaction.